MedPath

RANDOMISED CONTROLLED TRIAL TO COMPARE BETWEEN MELATONIN AND 24% SUCROSE FOR PAIN MANAGEMENT DURING ROP SCREENING

Phase 3
Conditions
Health Condition 1: -
Registration Number
CTRI/2021/02/031458
Lead Sponsor
KIMS HOSPITAL BHUBANESWAR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Neonate with gestational age <35 weeks, birth weight < 2000gms, requiring ROP screen and who are on atleast partial oral feeds .

Exclusion Criteria

Neonates on mechanical ventilation and/or ionotropic support during ROP screening.

Neonates on opioid analgesics, sedatives or anticonvulsants during ROP screening.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PIPP SCORE during ROP screening ,at 1 minute after and 5 minute after the procedure in both armsTimepoint: PIPP SCORE during ROP screening ,at 1 minute after and 5 minute after the procedure in both arms
Secondary Outcome Measures
NameTimeMethod
umber of neonates in both arms requiring additional analgesia. <br/ ><br>Any observed adverse effects of Melatonin. <br/ ><br>Timepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath